“Pyrotinib: A Promising Tyrosine Kinase Inhibitor for Treating Breast Cancer”. Molecular Medicine Communications, vol. 4, no. 01, June 2024, pp. 43-57, https://doi.org/10.55627/mmc.004.001.0553.